Maria-Victoria Mateos-Manteca (María-Victoria Mateos, Maria-Victoria Mateos, Maria-Victoria Mateos Manteca, M V Mateos, Maria V Mateos, Maria Victoria Mateos, María Victoria Mateos, Maria Victoria Mateos Manteca)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 97

Top Topics

Multiple Myeloma

Prognostic Factors

Top Venues

Blood cancer journal

Leukemia & lymphoma

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Rémi Tilmont, Ibrahim Yakoub-Agha, Diderik-Jan Eikema, Nienke Zinger, Mathias Haenel, Nicolaas Schaap, Concepcion Herrera Arroyo, Christine Schuermans, Britta Besemer, Monika Engelhardt, Jürgen H E Kuball, Mariagrazia Michieli, Natalie Schub, Keith M O Wilson, Jean Henri Bourhis, Maria-Victoria Mateos-Manteca, Neil Rabin, Edgar Jost, Nicolaus Kroeger, José María Moraleda, Tommaso Za, Patrick J Hayden, Meral Beksac, Donal P McLornan, Stefan O Schönland, Salomon Manier
Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT. Bone marrow transplantation (2023)
Hareth Nahi, Saad Z Usmani, Maria-Victoria Mateos-Manteca, Niels W C J van de Donk, Albert Oriol, Torben Plesner, Nibedita Bandyopadhyay, Peter Hellemans, Brenda Tromp, Ivo Nnane, Donna Zemlickis, Ajai Chari, Philippe Moreau
Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study. Leukemia & lymphoma 64 (2) (2023)
Andrew Spencer, Philippe Moreau, Maria-Victoria Mateos-Manteca, Hartmut Goldschmidt, Kenshi Suzuki, Mark-David Levin, Pieter Sonneveld, Robert Z Orlowski, Sung Soo Yoon, Saad Z Usmani, Katja C Weisel, Donna Reece, Tahamtan Ahmadi, Huiling Pei, Wendy Garvin Mayo, Xue Gai, Jodi Carey, J Blake Bartlett, Robin Carson, Meletios-Athanasios A Dimopoulos
Daratumumab in Myeloma Patients With Early or Late Relapse After Initial Therapy: Subgroup Analysis of CASTOR and POLLUX. Blood advances (2023)
Hareth Nahi, Saad Z Usmani, Maria-Victoria Mateos-Manteca, Niels W C J van de Donk, Albert Oriol, Torben Plesner, Nibedita Bandyopadhyay, Peter Hellemans, Brenda Tromp, Ivo Nnane, Donna Zemlickis, Ajai Chari, Philippe Moreau
Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study. Leukemia & lymphoma 64 (2) (2023)
Noopur S Raje, Maria-Victoria Mateos-Manteca, Shinsuke Iida, Donna Reece
Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy. Blood cancer journal 13 (1) (2023)
Borja Puertas, Verónica González-Calle, Eduardo Sobejano-Fuertes, Fernando Escalante, Beatriz Rey-Bua, Irene Padilla, Miriam Santero, Noemi Puig, Norma C Gutiérrez, Maria-Victoria Mateos-Manteca
Multiple myeloma with t(11;14): impact of novel agents on outcome. Blood cancer journal 13 (1) (2023)
Borja Puertas, Verónica González-Calle, Eduardo Sobejano-Fuertes, Fernando Escalante, Beatriz Rey-Bua, Irene Padilla, Miriam Santero, Noemi Puig, Norma C Gutiérrez, Maria-Victoria Mateos-Manteca
Multiple myeloma with t(11;14): impact of novel agents on outcome. Blood cancer journal 13 (1) (2023)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikander Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez-Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Noopur S Raje, Maria-Victoria Mateos-Manteca, Shinsuke Iida, Donna Reece
Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy. Blood cancer journal 13 (1) (2023)
Cirino Botta, Cristina Perez, Marta Larrayoz, Noemi Puig, María-Teresa Cedena, Rosalinda Termini, Ibai Goicoechea, Sara Rodriguez, Aintzane Zabaleta, Aitziber Lopez, Sarai Sarvide, Laura Blanco, Daniele M Papetti, Marco S Nobile, Daniela Besozzi, Massimo Gentile, Pierpaolo Correale, Sergio Siragusa, Albert Oriol, Maria Esther González-Garcia, Anna Sureda, Felipe de Arriba, Rafael Rios-Tamayo, José María Moraleda, Mercedes Gironella, Miguel T Hernandez, Joan Bargay, Luis Palomera, Albert Pérez-Montaña, Hartmut Goldschmidt, Hervé Avet-Loiseau, Aldo M Roccaro, Alberto Orfao, Joaquin Martinez-Lopez, Laura Rosinol, Juan-José Lahuerta, Joan Bladé, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Jose-Angel Martinez-Climent, Juan José Lahuerta, null null, null null
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance. Nature communications 14 (1) (2023)
Borja Puertas, Verónica González De La Calle, Eduardo Sobejano-Fuertes, Fernando Escalante, José A Queizán, Abelardo Bárez-García, Jorge Labrador, José María Alonso-Alonso, Alfonso García de Coca, Alberto Cantalapiedra, Teresa Villaescusa, Carlos Aguilar, Elena Alejo-Alonso, Beatriz Rey-Bua, Lucía López-Corral, Miriam Santero, Noemi Puig, Norma C Gutiérrez, Maria-Victoria Mateos-Manteca
Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma. Cancers 15 (5) (2023)
Laura Rosinol, Albert Ortiol, Rafael Rios-Tamayo, María-Jesús Blanchard, Isidro Jarque, Joan Bargay, Miguel-Teodoro T Hernandez Garcia, Valentín Cabañas, Estrella Carrillo-Cruz, Anna Sureda, Joaquin Martinez Lopez, Isabel Krsnik, Maria-Esther Gonzalez, Luis Felipe Casado Montero, Josep-Maria Marti, Cristina Encinas, Felipe de Arriba, Luis Palomera, Maria Antonia Sampol, Yolanda Gonzalez-Montes, Elena Cabezudo, Juan José Lahuerta, Noemi Puig, Maria-Teresa Cedena, Javier de la Cruz, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Juan-José Lahuerta, Joan Bladé
LENALIDOMIDE AND DEXAMETHASONE WITH OR WITHOUT IXAZOMIB MAINTENANCE TAILORED BY RESIDUAL DISEASE STATUS IN MYELOMA. Blood (2023)
Schjesvold Fredrik, Heinz Ludwig, Maria-Victoria Mateos-Manteca, Alessandra Larocca, Haifaa Abdulhaq, Stefan Norin, Marcus Thuresson, Nicolaas A Bakker, Paul Gerard Richardson, Pieter Sonneveld
Melflufen in relapsed/refractory multiple myeloma refractory to prior alkylators: A subgroup analysis from the OCEAN study. European journal of haematology (2023)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikander Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez-Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Saad Z Usmani, Hang Quach, Maria-Victoria Mateos-Manteca, Carl Ola Landgren, Xavier Leleu, David S Siegel, Katja C Weisel, Xiaomei Shu, Chuang Li, Meletios A Dimopoulos
Final Analysis of Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone in the CANDOR Study. Blood advances (2023)
Hareth Nahi, Saad Z Usmani, Maria-Victoria Mateos-Manteca, Niels W C J van de Donk, Albert Oriol, Torben Plesner, Nibedita Bandyopadhyay, Peter Hellemans, Brenda Tromp, Ivo Nnane, Donna Zemlickis, Ajai Chari, Philippe Moreau
Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study. Leukemia & lymphoma 64 (2) (2023)
Enrique María Ocio, Aurore Perrot, Pierre Bories, Jesús San F Miguel, Igor W Blau, Lionel Karlin, Joaquin Martinez-Lopez, Song-Yau Wang, Sara Bringhen, Magda Marcatti, Maria-Victoria Mateos-Manteca, Paula Rodriguez-Otero, Stefania Oliva, Axel Nogai, Nadia Le Roux, Liyan Dong, Sandrine Macé, Matthieu Gassiot, Thomas Fitzmaurice, Corina Oprea, Phillipe Moreau
Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation. Leukemia (2023)
Maria-Victoria Mateos-Manteca, Sikander Ailawadhi, Luciano José Megale Costa, Shakira J Grant, Lalit Kumar, Mohamad Mohty, Didem Aydin, Saad Z Usmani
Global disparities in patients with multiple myeloma: a rapid evidence assessment. Blood cancer journal 13 (1) (2023)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikander Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez-Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Hareth Nahi, Saad Z Usmani, Maria-Victoria Mateos-Manteca, Niels W C J van de Donk, Albert Oriol, Torben Plesner, Nibedita Bandyopadhyay, Peter Hellemans, Brenda Tromp, Ivo Nnane, Donna Zemlickis, Ajai Chari, Philippe Moreau
Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study. Leukemia & lymphoma (2023)
Camilla Guerrero, Noemi Puig, María-Teresa Cedena, María-José Calasanz, Norma C Gutiérrez, Manuela Fernandez, Albert Ortiol, Rafael Rios-Tamayo, Miguel-Teodoro T Hernandez Garcia, Rafael Martínez-Martínez, Joan Bargay, Felipe de Arriba, Luis Palomera, Ana Pilar Gonzalez-Rodriguez, Marta-Sonia Gonzalez Perez, Alberto Orfao, Maria-Victoria Mateos-Manteca, Joaquin Martinez-Lopez, Laura Rosinol, Joan Bladé, Juan-José Lahuerta, Jesús San F Miguel, Juan José Lahuerta
Predictors of unsustained measurable residual disease negativity in transplant-eligible multiple myeloma patients. Blood (2023)
Borja Puertas, Verónica González De La Calle, Eduardo Sobejano-Fuertes, Fernando Escalante, José A Queizán, Abelardo Bárez-García, Jorge Labrador, José María Alonso-Alonso, Alfonso García de Coca, Alberto Cantalapiedra, Teresa Villaescusa, Carlos Aguilar, Elena Alejo-Alonso, Beatriz Rey-Bua, Lucía López-Corral, Miriam Santero, Noemi Puig, Norma C Gutiérrez, Maria-Victoria Mateos-Manteca
Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma. Cancers 15 (5) (2023)
Noopur S Raje, Maria-Victoria Mateos-Manteca, Shinsuke Iida, Donna Reece
Correction: Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy. Blood cancer journal 13 (1) (2023)
Hareth Nahi, Saad Z Usmani, Maria-Victoria Mateos-Manteca, Niels W C J van de Donk, Albert Oriol, Torben Plesner, Nibedita Bandyopadhyay, Peter Hellemans, Brenda Tromp, Ivo Nnane, Donna Zemlickis, Ajai Chari, Philippe Moreau
Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study. Leukemia & lymphoma 64 (2) (2023)
Maria-Victoria Mateos-Manteca, Verónica González De La Calle
Lenalidomide maintenance based on a genetic profile. Blood 141 (14) (2023)
Hareth Nahi, Saad Z Usmani, Maria-Victoria Mateos-Manteca, Niels W C J van de Donk, Albert Oriol, Torben Plesner, Nibedita Bandyopadhyay, Peter Hellemans, Brenda Tromp, Ivo Nnane, Donna Zemlickis, Ajai Chari, Philippe Moreau
Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study. Leukemia & lymphoma 64 (2) (2023)
Borja Puertas, Verónica González-Calle, Eduardo Sobejano-Fuertes, Fernando Escalante, Beatriz Rey-Bua, Irene Padilla, Miriam Santero, Noemi Puig, Norma C Gutiérrez, Maria-Victoria Mateos-Manteca
Multiple myeloma with t(11;14): impact of novel agents on outcome. Blood cancer journal 13 (1) (2023)
Noopur S Raje, Kenneth C Anderson, Hermann Einsele, Yvonne Efebera, Francesca Gay, Sarah P Hammond, Alexander M Lesokhin, Sagar Lonial, Heinz Ludwig, Phillipe Moreau, Krina Patel, Karthik Ramasamy, Maria-Victoria Mateos-Manteca
Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel. Blood cancer journal 13 (1) (2023)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikander Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez-Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Borja Puertas, Verónica González-Calle, Eduardo Sobejano-Fuertes, Fernando Escalante, Beatriz Rey-Bua, Irene Padilla, Miriam Santero, Noemi Puig, Norma C Gutiérrez, Maria-Victoria Mateos-Manteca
Multiple myeloma with t(11;14): impact of novel agents on outcome. Blood cancer journal 13 (1) (2023)
Kristine A Frerichs, Christie P M Verkleij, Maria-Victoria Mateos-Manteca, Thomas Martin, Cesar Rodriguez, Ajay K Nooka, Arnob Banerjee, Katherine Chastain, Alfredo Perales-Puchalt, Tara Stephenson, Clarissa Uhlar, Rachel Kobos, Bronno van der Holt, Sandy Kruyswijk, Maria T Kuipers, Kazimierz Groen, Deeksha Vishwamitra, Sheri Skerget, Diana Cortes-Selva, Margaret Doyle, Hans L Zaaijer, Sonja Zweegman, Raluca I Verona, Niels W C J van de Donk
Teclistamab impairs humoral immunity in heavily pretreated MM patients: importance of immunoglobulin supplementation. Blood advances (2023)
Leire Burgos, Luis-Esteban Tamariz-Amador, Noemi Puig, María-Teresa Cedena, Camilla Guerrero, Tomas Jelinek, Sarah Johnson, Paolo Milani, Lourdes Cordon, Jose J Perez, Marta Lasa, Rosalinda Termini, Albert Ortiol, Miguel-Teodoro T Hernandez Garcia, Luis Palomera, Rafael Martinez-Martinez, Javier de la Rubia, Felipe de Arriba, Rafael Rios-Tamayo, Maria-Esther Gonzalez, Mercedes Gironella, Valentín Cabañas, Maria Casanova, Isabel Krsnik, Albert Perez-Montaña, Verónica González De La Calle, Paula Rodriguez-Otero, Vladimir Maisnar, Roman Hájek, Frits van Rhee, Victor Jimenez-Zepeda, Giovanni Palladini, Giampaolo Merlini, Alberto Orfao, Javier de la Cruz, Joaquin Martinez Lopez, Juan-José Lahuerta, Laura Rosinol, Joan Blade, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Juan José Lahuerta, null null
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Noopur S Raje, Maria-Victoria Mateos-Manteca, Shinsuke Iida, Donna Reece
Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy. Blood cancer journal 13 (1) (2023)
Noemí Puig, María-Teresa Contreras, Cristina Agulló, Joaquin Martinez Lopez, Albert Ortiol, María-Jesús Blanchard, Rafael Rios-Tamayo, Jesús Martín, María-Belén Iñigo, Anna Sureda, Miguel-Teodoro T Hernandez Garcia, Javier de la Rubia, Verónica González De La Calle, Isabel Krsnik, Valentín Cabañas, Luis Palomera, José María Moraleda, Joan Bargay, María-Teresa Cedena, Juan José Lahuerta, Laura Rosiñol, Joan Bladé, Jesús San F Miguel, Juan-José Lahuerta, Maria-Victoria Mateos-Manteca
Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma. Blood advances 6 (11) (2022)
Adam David Cohen, Samir Parekh, Bianca D Santomasso, Jaime Gállego Pérez-Larraya, Niels W C J van de Donk, Bertrand Arnulf, Maria-Victoria Mateos-Manteca, Nikoletta Lendvai, Carolyn C Jackson, Kevin C De Braganca, Jordan M Schecter, Loreta Marquez, Erin Lee, Ingrid Cornax, Enrique Zudaire, Claire Li, Yunsi Olyslager, Deepu Madduri, Helen Varsos, Lida Pacaud, Muhammad Akram, Dong Geng, Andrzej J Jakubowiak, Hermann Einsele, Sundar Jagannath
Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies. Blood cancer journal 12 (2) (2022)
Juan-José Garcés, María-Teresa Cedena, Noemi Puig, Leire Burgos, Jose J Perez, Lourdes Cordon, Juan A Flores-Montero, Luzalba Sanoja-Flores, María-José Calasanz, Albert Ortiol, María-Jesús Blanchard, Rafael Rios-Tamayo, Jesús Martín-Sánchez, Rafael Martínez-Martinez, Joan Bargay, Anna Sureda, Javier de la Rubia, Miguel-Teodoro T Hernandez Garcia, Paula Rodriguez-Otero, Javier de la Cruz, Alberto Orfao, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Juan-José Lahuerta, Laura Rosinol, Joan Blade, Jesús San F Miguel, Juan José Lahuerta
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (27) (2022)
Maria-Victoria Mateos-Manteca, Katja C Weisel, Valerio De Stefano, Hartmut Goldschmidt, Michel Delforge, Mohamad Mohty, Michele Cavo, Ravi Vij, Joanne Lindsey-Hill, Dominik Dytfeld, Emanuele Angelucci, Aurore Perrot, Reuben Benjamin, Niels W C J van de Donk, Enrique M Ocio, Christof Scheid, Francesca Gay, Wilfried Roeloffzen, Paula Rodriguez-Otero, Annemiek Broijl, Anna Potamianou, Caline Sakabedoyan, Maria Semerjian, Sofia Keim, Vadim Strulev, Jordan M Schecter, Martin Vogel, Robert Wapenaar, Tonia Nesheiwat, Jesús San F Miguel, Pieter Sonneveld, Hermann Einsele, Philippe Moreau
LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma. Leukemia 36 (5) (2022)
Juan Manuel Rosa-Rosa, Isabel Cuenca, Alejandro Medina, Iria Vazquez, Andrea Sánchez-delaCruz, Natalia Buenache, Ricardo Sanchez, Cristina Jiménez, Laura Rosinol, Norma C Gutiérrez, Yanira Ruiz-Heredia, Santiago Barrio, Albert Oriol, Maria-Luisa Martin-Ramos, María-Jesús Blanchard, Rosa María Ayala, Rafael Ríos-Tamayo, Anna Sureda, Miguel-Teodoro Hernández, Javier de la Rubia, Gorka Alkorta-Aranburu, Xabier Agirre, Joan Bladé, Maria-Victoria Mateos-Manteca, Juan-José Lahuerta, Jesús F San-Miguel, María-José Calasanz, Miriam Santero, Joaquín Martínez-Lopez
NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial. Cancers 14 (20) (2022)
Adrián Mosquera Orgueira, Marta Sonia González Pérez, Jose Diaz Arias, Laura Rosinol, Albert Ortiol, Ana Isabel Teruel, Joaquin Martinez Lopez, Luis Palomera, Miquel Granell, Maria Jesus Blanchard, Javier de la Rubia, Ana López de la Guia, Rafael Rios-Tamayo, Anna Sureda, Miguel-Teodoro T Hernandez Garcia, Enrique Bengoechea, María José Calasanz, Norma Gutierrez, Maria Luis Martin, Joan Bladé, Juan-José Lahuerta, Jesús San F Miguel, Maria-Victoria Mateos-Manteca, null null
Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group. Blood cancer journal 12 (4) (2022)
Luciano José Megale Costa, Vania Tietsche de Moraes Hungria, Mohamad Mohty, Maria-Victoria Mateos-Manteca
How I treat triple-class refractory multiple myeloma. British journal of haematology 198 (2) (2022)
Mark A Dawson, Gautam Borthakur, Brian James Patrick Huntly, Anastasios Karadimitris, Adrian Alegre, Aristeidis Chaidos, Dan T Vogl, Daniel A Pollyea, Faith E Davies, Gareth J Morgan, Jacob Lowell Glass, Manali Kamdar, Maria-Victoria Mateos-Manteca, Natalia Tovar, Paul Yeh, Regina García Delgado, Faisal Basheer, Ludovica Marando, Paolo Gallipoli, Anastasia Wyce, Anu Shilpa Krishnatry, Olena Barbash, Evi Bakirtzi, Geraldine Ferron-Brady, Natalie O Karpinich, Michael T McCabe, Shawn W Foley, Thierry Horner, Arindam Dhar, Brandon E Kremer, Michael J Dickinson
A phase I/II open-label study of molibresib for the treatment of relapsed/refractory hematologic malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Paul G Richardson, Maria-Victoria Mateos-Manteca, Annette J Vangsted, Karthik Ramasamy, Niels Abildgaard, P Joy Ho, Hang Quach, Nizar J Bahlis
The role of E3 ubiquitin ligase in multiple myeloma: potential for cereblon E3 ligase modulators in the treatment of relapsed/refractory disease. Expert review of proteomics (2022)
Maria-Victoria Mateos-Manteca, Sophie Rigaudeau, Supratik Basu, Ivan Spicka, Rik Schots, Tomasz Wrobel, Gordon Cook, Meral Beksac, Katharine S Gries, Anupa Kudva, Brenda Tromp, Rian Van Rampelbergh, Huiling Pei, Susan Wroblewski, Robin Carson, Maria Delioukina, Darrell White
Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)
Enrique María Ocio, Omar Nadeem, Fredrik Schjesvold, Francesca Gay, Cyrille Touzeau, Meletios- Athanasios Dimopoulos, Paul G Richardson, Maria-Victoria Mateos-Manteca
Melflufen for the treatment of multiple myeloma. Expert review of clinical pharmacology 15 (4) (2022)
Luciano J Costa, Parameswaran Hari, Jesus G Berdeja, Valerio De Stefano, Francesca Gay, Becky Hooper, Meaghan Bartlett, Anja Haltner, Emily Rosta, Shaji K Kumar, Thomas Martin, Maria-Victoria Mateos-Manteca, Philippe Moreau, Saad Z Usmani, Yunsi Olyslager, Jordan M Schecter, Tito Roccia, Ashraf Garrett, Sam Lee, Tonia Nesheiwat, Lida Pacaud, Changwei Zhou, Imtiaz A Samjoo, Yi Lin, Joris Diels, Satish Valluri, Katja Weisel
Meta-analysis of ciltacabtagene autoleucel versus physician's choice therapy for the treatment of patients with relapsed or refractory multiple myeloma. Current medical research and opinion 38 (10) (2022)
Francisco-Javier Cepeda-Piorno, Maria-Esther Gonzalez, Alba Méndez-Gallego, Juan Torres-Varona, Vanesa García-Moreira, Christian Sordo-Bahamonde, Cristina AlberdiGarcía-Del-Castillo, Elene Astobieta-Madariaga, Maria-Victoria Mateos-Manteca, Segundo González
Cystatin C-Based Equations Detect Hidden Kidney Disease and Poor Prognosis in Newly Diagnosed Patients with Multiple Myeloma. Advances in hematology 2022 (2022)
Rosalinda Termini, David Zihala, Evangelos Terpos, Albert Perez-Montaña, Tomas Jelinek, Marc-Steffen Raab, Niels Weinhold, Elias Karl Mai, Anna Luise Grab, Jill Corre, François Vergez, Antonio Sacco, Marco Chiarini, Viviana Giustini, Alessandra Tucci, Sara Rodriguez, Cristina Moreno, Cristina Perez, Catarina Maia, Esperanza Martín-Sánchez, Camilla Guerrero, Cirino Botta, Juan-José Garcés, Aitziber Lopez, Luis-Esteban Tamariz-Amador, Felipe Prosper, Joan Bargay, Maria-Elena Cabezudo, Enrique María Ocio, Roman Hájek, Joaquin Martinez Lopez, Fernando Solano, Rebeca Iglesias, Artur Paiva, Catarina Geraldes, Helena Vitoria, Clara Gomez, Felipe De Arriba, Heinz Ludwig, Antoni Garcia-Guiñon, María Casanova, Adrian Alegre, Valentín Cabañas, Maialen Sirvent, Albert Ortiol, Javier de la Rubia, Jose-Ángel Hernández-Rivas, Luis Palomera, Maria Sarasa, Pablo Rios, Noemi Puig, Maria-Victoria Mateos-Manteca, Juan A Flores-Montero, Alberto Orfao, Hartmut Goldschmidt, Herve Avet-Loiseau, Aldo M Roccaro, Jesús San F Miguel, Juan José Lahuerta, null null
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Elias Campo, Elaine S Jaffe, James R Cook, Leticia Quintanilla-Martínez, Steven H Swerdlow, Kenneth C Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, Stefan Dirnhofer, Ahmet Dogan, Andrew L Feldman, Falko Fend, Jonathan W Friedberg, Philippe Gaulard, Paolo Ghia, Steven M Horwitz, Rebecca L King, Gilles Andre Salles, Jesús San F Miguel, John Francis Seymour, Steven P Treon, Julie M Vose, Emanuele Zucca, Ranjana Advani, Stephen Ansell, Wing-Yan Au, Carlos Barrionuevo, Peter Leif Bergsagel, Wing C Chan, Jeffrey I Cohen, Francesco d'Amore, Andrew John Davies, Brunangelo Falini, Irene M Ghobrial, Mariusz A Wasik, John G Gribben, Eric D Hsi, Brad S Kahl, Won-Seog Kim, Shaji K Kumar, Ann Steward LaCasce, Camille Laurent, Georg Lenz, John P Leonard, Michael P Link, Armando Lopez-Guillermo, Maria-Victoria Mateos-Manteca, Elizabeth A Macintyre, Ari M Melnick, Judith Trotman, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano A Pileri, Miguel Angel Piris, Barbara Pro, Vincent Rajkumar, Steven T Rosen, Birgitta Sander, Laurie Sehn, Margaret A Shipp, Sonali M Smith, Louis M Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H Wilson, Tadashi Yoshino, Pier Luigi Luigi Zinzani, Martin Dreyling, David W Scott, Jane N Winter, Andrew D Zelenetz
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood 140 (11) (2022)
Cristina De Ramón-Sánchez, Elizabeta A Rojas, Ignacio J Cardona-Benavides, Maria-Victoria Mateos-Manteca, Luis A Corchete, Norma C Gutiérrez
Transcriptional signature of TP53 biallelic inactivation identifies a group of multiple myeloma patients without this genetic condition but with dismal outcome. British journal of haematology 199 (3) (2022)
Juan José Lahuerta, Irene Manrique, Meletios A Dimopoulos, Francesca Gay, Chang-Ki Min, Sonja Zweegman, Ivan Spicka, Raphael Teipel, Maria-Victoria Mateos-Manteca, Nicola Giuliani, Michele Cavo, Christine Rojas, Weijun Fu, Kaveri Suryanarayan, Alexander Vorog, Cong Li, Bingxia Wang, Jose Estevam, Richard Labotka, Ajeeta B Dash
MRD dynamics during maintenance for improved prognostication of 1280 myeloma patients in TOURMALINE-MM3 and -MM4 trials. Blood (2022)
Adam David Cohen, Maria-Victoria Mateos-Manteca, Yael C Cohen, Paula Rodriguez-Otero, Juan José Lahuerta, Niels W C J van de Donk, Thomas G Martin, Attaya Suvannasankha, Kevin C De Braganca, Christina Corsale, Jordan M Schecter, Helen Varsos, William Deraedt, Liwei Wang, Martin Vogel, Tito Roccia, Xiaoying Xu, Pankaj Mistry, Enrique Zudaire, Muhammad Akram, Tonia Nesheiwat, Lida Pacaud, Irit Avivi, Jesús San F Miguel
Efficacy and safety of cilta-cel in patients with progressive MM after exposure to other BCMA-targeting agents. Blood (2022)
Pieter Sonneveld, Asher Chanan-Khan, Katja Weisel, Ajay K Nooka, Tamas Masszi, Meral Beksac, Ivan Spicka, Vania Tietsche de Moraes Hungria, Markus Munder, Maria-Victoria Mateos-Manteca, Tomer M Mark, Mark-David Levin, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Andrew Spencer
Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Tomas Jelinek, Renata Bezděková, David Zihala, Tereza Ševčíková, Anjana Anilkumar Sithara, Lenka Pospisilova, Sabina Sevcikova, Petra Polackova, Martin Stork, Zdenka Knechtova, Ondrej Venglar, Veronika Kapustová, Tereza Popkova, Ludmila Muronova, Zuzana Chyra, Matous Hrdinka, Michal Simicek, Juan-José Garcés, Noemi Puig, María-Teresa Cedena, Artur Jurczyszyn, Jorge J Castillo, Miroslav Penka, Jakub Radocha, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Juan José Lahuerta, Ludek Pour, Lucie Říhová, Roman Hájek
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Maria-Victoria Mateos-Manteca, Felipe Prosper, Jesús Martín-Sánchez, Enrique M Ocio, Albert Oriol, Cristina Motlló, Jean Marie Michot, Isidro Jarque, Rebeca Iglesias, María Solé, Sara Martínez, Carmen Kahatt, Salvador Fudio, Gema Corral, Ali Zeaiter, Lola Montilla, Vincent Ribrag
Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma. Cancer medicine (2022)
Sundararajan Vincent Rajkumar, Shaji K Kumar, Sagar Lonial, Maria-Victoria Mateos-Manteca
Smoldering multiple myeloma current treatment algorithms. Blood cancer journal 12 (9) (2022)
Cristina Encinas, José-Ángel Hernandez-Rivas, Albert Ortiol, Laura Rosiñol, María-Jesús Blanchard, José-María Bellón, Miriam Santero, Javier de la Rubia, Ana López de la Guía, Ana Jímenez-Ubieto, Isidro Jarque, Belén Iñigo, Victoria Dourdil, Felipe De Arriba, Clara Cuéllar Pérez-Ávila, Yolanda Gonzalez, Miguel-Teodoro Hernández, Joan Bargay, Miquel Granell, Paula Rodríguez-Otero, Maialen Silvent, Carmen Cabrera, Rafael Rios, Adrian Alegre, Mercedes Gironella, Marta-Sonia Gonzalez, Anna Sureda, Maria Antonia Sampol, Enrique M Ocio, Isabel Krsnik, Antonio García, Aránzazu García-Mateo, Joan-Alfons Soler, Jesús Martín-Sánchez, José-María Arguiñano, Maria-Victoria Mateos-Manteca, Joan Bladé, Jesús San F Miguel, Juan-José Lahuerta, Joaquin Martinez Lopez, null null
A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma. Blood cancer journal 12 (4) (2022)
Julio Dávila-Valls, Verónica González-Calle, Fernando Escalante, Seila Cerdá, Noemí Puig, Miriam Santero, Abelardo Bárez, Carmen Montes, Rosa López, José María Alonso, Carlos Aguilar, Aránzazu García-Mateo, Jorge Labrador, Carmen Aguilera, Alfonso García-Coca, Roberto Hernández, Maria-Victoria Mateos-Manteca, Enrique María Ocio
Recovery of polyclonal immunoglobulins during treatment in patients ineligible for autologous stem-cell transplantation is a prognostic marker of longer progression-free survival and overall survival. British journal of haematology 198 (2) (2022)
Mattia D'Agostino, David A Cairns, Juan-José Lahuerta, Ruth Wester, Uta Bertsch, Anders Waage, Elena Zamagni, Maria-Victoria Mateos-Manteca, Daniele Dall'Olio, Niels W C J van de Donk, Graham H Jackson, Serena Rocchi, Hans J Salwender, Joan Bladé Creixenti, Bronno van der Holt, Gastone C Castellani, Francesca Bonello, Andrea Capra, Elias Karl Mai, Jan Dürig, Francesca Gay, Sonja Zweegman, Michele Cavo, Martin F Kaiser, Hartmut Goldschmidt, Jesús María Hernández-Rivas, Alessandra Larocca, Curly T C M Morris, Jesús San F Miguel, Mario Boccadoro, Pieter Sonneveld
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)
Cirino Botta, Catarina Da Silva Maia, Juan-José Garcés, Rosalinda Termini, Cristina Perez, Irene Manrique, Leire Burgos, Aintzane Zabaleta, Diego Alignani, Sarai Sarvide, Juana Merino, Noemi Puig, Maria-Teresa Cedena, Marco Rossi, Pierfrancesco Tassone, Massimo Gentile, Pierpaolo Correale, Ivan M Borrello, Evangelos Terpos, Tomas Jelinek, Artur Paiva, Aldo M Roccaro, Hartmut Goldschmidt, Herve Avet-Loiseau, Laura Rosinol, Maria-Victoria Mateos-Manteca, Joaquin Martinez-Lopez, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Juan José Lahuerta
FlowCT for the analysis of large immunophenotypic datasets and biomarker discovery in cancer immunology. Blood advances (2021)
Jesús San F Miguel, Hervé Avet-Loiseau, Juan José Lahuerta, Shaji K Kumar, Meletios A A Dimopoulos, Thierry Facon, Maria-Victoria Mateos-Manteca, Cyrille Touzeau, Andrzej J Jakubowiak, Saad Z Usmani, Gordon Cook, Michele Cavo, Hang Quach, Jon Ukropec, Priya Ramaswami, Huiling Pei, Mia Qi, Steven Sun, Jianping Wang, Maria Krevvata, Nikki DeAngelis, Christoph Heuck, Rian Van Rampelbergh, Anupa Kudva, Rachel Kobos, Ming Qi, Nizar J Bahlis
Sustained Minimal Residual Disease Negativity With Daratumumab in Newly Diagnosed Multiple Myeloma: MAIA and ALCYONE. Blood (2021)
Noemí Puig, Juan A Flores-Montero, Leire Burgos, María-Teresa Cedena, Lourdes Cordón, José-Juan Pérez, Luzalba Sanoja-Flores, Irene Manrique, Paula Rodríguez-Otero, Laura Rosiñol, Joaquin Martinez Lopez, Maria-Victoria Mateos-Manteca, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Alberto Orfao, Juan José Lahuerta
Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma. Cancers 13 (19) (2021)
Vania Tietsche de Moraes Hungria, Meral Beksac, Katja C Weisel, Ajay K Nooka, Tamas Masszi, Ivan Spicka, Markus Munder, Maria-Victoria Mateos-Manteca, Tomer M Mark, Ming Qi, Xiang Qin, John Fastenau, Andrew Spencer, Pieter Sonneveld, Wendy Garvin, Thomas Renaud, Katharine S Gries
Health-related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial. British journal of haematology 193 (3) (2021)
Daniel Alameda, Ibai Goicoechea, Marco Vicari, Elena Arriazu, Alice Nevone, Sara Rodriguez, Marta Lasa, Noemi Puig, Maria Teresa Cedena, Diego Alignani, Sonia Garate, David Lara-Astiaso, Amaia Vilas-Zornoza, Sarai Sarvide, Enrique María Ocio, Ramon Lecumberri, Alfonso Garcia de Coca, Jorge Labrador, Maria-Esther Gonzalez, Luis Palomera, Mercedes Gironella, Valentín Cabañas, Maria Casanova, Albert Ortiol, Isabel Krsnik, Albert Perez-Montaña, Javier de la Rubia, José Enrique de la Puerta, Felipe de Arriba, Vito Michele Fazio, Joaquin Martinez Lopez, Juan-José Lahuerta, Maria-Victoria Mateos-Manteca, Maria-Dolores Odero, Felipe Prosper, Assaf Weiner, Ido Amit, Mario Nuvolone, Jesús San F Miguel, Juan José Lahuerta
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development. Blood 138 (17) (2021)
Adrián Mosquera Orgueira, Marta Sonia González Pérez, José Ángel Díaz Arias, Beatriz Antelo Rodríguez, Natalia Alonso Vence, Ángeles Bendaña López, Aitor Abuín Blanco, Laura Bao Pérez, Andrés Peleteiro Raíndo, Miguel Cid López, Manuel Mateo Pérez Encinas, José Luis Bello López, Maria-Victoria Mateos-Manteca
Survival prediction and treatment optimization of multiple myeloma patients using machine-learning models based on clinical and gene expression data. Leukemia 35 (10) (2021)
Carlos Fernández de Larrea, Robert Kyle, Laura Rosinol, Juan José Lahuerta, Monika Engelhardt, Saad Z Usmani, Jo Caers, Wilson Gonsalves, Schjesvold Fredrik, Giampaolo Merlini, Suzanne Lentzch, Enrique Ocio, Laurent Garderet, Philippe Moreau, Pieter Sonneveld, Ashraf Badros, Gösta Gahrton, Hartmut Goldschmidt, Sascha A Tuchman, Hermann Einsele, Brian Durie, Baldeep Wirk, Pellegrino Musto, Patrick Hayden, Martin F Kaiser, Jesús San F Miguel, Joan Bladé, Sundararajan Vincent Rajkumar, Maria-Victoria Mateos-Manteca
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage. Blood cancer journal 11 (12) (2021)
Andrea Díaz-Tejedor, Mauro Lorenzo-Mohamed, Noemí Puig, Miriam Santero, Maria-Victoria Mateos-Manteca, Mercedes Garayoa, Teresa Paíno
Immune System Alterations in Multiple Myeloma: Molecular Mechanisms and Therapeutic Strategies to Reverse Immunosuppression. Cancers 13 (6) (2021)
Laura Rosinol, Meral Beksac, Elena Zamagni, Niels W C J Van de Donk, Kenneth C Anderson, Ashraf Badros, Jo Caers, Michele Cavo, Meletios- Athanasios Dimopoulos, Angela Dispenzieri, Hermann Einsele, Monika Engelhardt, Carlos Fernández de Larrea, Gösta Gahrton, Francesca Gay, Roman Hájek, Vania Hungria, Artur Jurczyszyn, Nicolaus Kröger, Robert A Kyle, Fernando Leal da Costa, Xavier Leleu, Suzanne Lentzsch, Maria-Victoria Mateos-Manteca, Giampaolo Merlini, Mohamad Mohty, Phillipe Moreau, Leo Rasche, Donna Reece, Orhan Sezer, Pieter Sonneveld, Saad Z Usmani, Karin Vanderkerken, David H Vesole, Anders Waage, Sonja Zweegman, Paul Gerard Richardson, Joan Bladé
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations. British journal of haematology 194 (3) (2021)
Evangelos Terpos, Joseph Mikhael, Roman Hájek, Ajai Chari, Sonja Zweegman, Hans C Lee, Maria-Victoria Mateos-Manteca, Alessandra Larocca, Karthik Ramasamy, Martin F Kaiser, Gordon Cook, Katja C Weisel, Caitlin L Costello, Jennifer Elliott, Antonio Palumbo, Saad Z Usmani
Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life. Blood cancer journal 11 (2) (2021)
Hang Quach, Ajay Nooka, Olga Samoylova, Christopher P Venner, Kihyun Kim, Thierry Facon, Andrew Spencer, Saad Z Usmani, Sebastian Grosicki, Kenshi Suzuki, Sosana Delimpasi, Katja Weisel, Mihaela Obreja, Anita Zahlten-Kumeli, Maria-Victoria Mateos-Manteca
Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy. British journal of haematology 194 (4) (2021)
Robéria M Pontes, Juan A Flores-Montero, Luzalba Sanoja-Flores, Noemi Puig, Roberto J Pessoa de Magalhães, Alba Corral-Mateos, Anna Beatriz Salgado, Omar García-Sánchez, José Pérez-Morán, Maria-Victoria Mateos-Manteca, Leire Burgos, Bruno Paiva, Jeroen Te Marvelde, Vincent H J van der Velden, Carlos Aguilar, Abelardo Bárez-García, Aranzazú García-Mateo, Jorge Labrador, Pilar Leoz, Carmen Aguilera-Sanz, Brian Durie, Jacques J M van Dongen, Angelo Maiolino, Elaine Sobral da Costa, Alberto Orfao
B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma Patients. Cancers 13 (7) (2021)
Noemi Puig, Miguel-Teodoro T Hernandez Garcia, Laura Rosiñol, Esther González, Felipe de Arriba, Albert Ortiol, Verónica González-Calle, Fernando Escalante, Javier de la Rubia, Mercedes Gironella, Rafael Ríos, Ricarda García-Sánchez, José M Arguiñano, Adrián Alegre, Jesús Martín-Sánchez, Norma C Gutiérrez, María-José Calasanz, María L Martín, María Del Carmen Couto, María Casanova, Mario Arnao, Ernesto Pérez-Persona, Sebastián Garzón, Marta S González, Guillermo Martín-Sánchez, Enrique M Ocio, Morton Coleman, Cristina Encinas, Ana M Vale, Ana I Teruel, María Cortés-Rodríguez, Juan José Lahuerta, M Teresa Cedena, Jesús San F Miguel, Juan-José Lahuerta, Joan Bladé, Ruben Niesvizky, Maria-Victoria Mateos-Manteca
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial. Blood cancer journal 11 (5) (2021)
Ana Jiménez-Ubieto, Juan José Lahuerta, Noemi Puig, María-Teresa Cedena, Joaquin Martinez Lopez, Albert Ortiol, María-Jesús Blanchard, Rafael Ríos, Jesús Martin, Rafael Martínez, Anna Sureda, Miguel-Teodoro T Hernandez Garcia, Javier de la Rubia, Isabel Krsnik, Valentín Cabañas, Luis Palomera, José María Sánchez-Pina, Joan Bargay, Maria-Victoria Mateos-Manteca, Laura Rosinol, Joan Blade, Jesús San F Miguel, Juan-José Lahuerta, null null
Validation of the International Myeloma Working Group standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change? Blood 138 (19) (2021)
José Luis Piñana, Lourdes Vázquez, Rodrigo Martino Bofarull, Rafael de la Cámara, Anna Sureda, Rebeca Rodríguez-Veiga, Ana Garrido, Marta Pratcorona, Josep-María Ribera, Anna Torrent, Maria-Victoria Mateos-Manteca, Javier de la Rubia, María Del Mar Tormo Díaz, María Díez-Campelo, Valentín García-Gutiérrez, Alberto Álvarez-Larrán, Juan-Manuel Sancho, Alejandro MartínGarcía-Sancho, Lucrecia Yañez, José Antonio Pérez Simón, Pere Barba, Pau Abrisqueta, Iván Álvarez-Twose, Santiago Bonanad, Ramón Lecumberri, Isabel Ruiz-Camps, David Navarro, José-Ángel Hernández-Rivas, Ángel Cedillo, Ramón García-Sanz, Francesc Bosch
Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients. Leukemia & lymphoma (2021)
Michele Cavo, Jesús San F Miguel, Saad Z Usmani, Katja C Weisel, Meletios A A Dimopoulos, Hervé Avet-Loiseau, Juan José Lahuerta, Nizar J Bahlis, Torben Plesner, Vania Tietsche de Moraes Hungria, Philippe Moreau, Maria-Victoria Mateos-Manteca, Aurore Perrot, Shinsuke Iida, Thierry Facon, Shaji K Kumar, Niels W C J van de Donk, Pieter Sonneveld, Andrew Spencer, Maria Krevvata, Christoph Heuck, Jianping Wang, Jon Ukropec, Rachel Kobos, Steven Sun, Mia Qi, Nikhil C Munshi
Prognostic value of minimal residual disease negativity in myeloma: combined analysis of POLLUX, CASTOR, ALCYONE, MAIA. Blood (2021)
Alessandra Larocca, Xavier Leleu, Cyrille Touzeau, Joan Bladé, Agne Paner, Maria-Victoria Mateos-Manteca, Michele Cavo, Christopher Maisel, Adrían Alegre, Albert Oriol, Anastasios Raptis, Paula Rodriguez-Otero, Amitabha Mazumder, Jacob P Laubach, Omar Nadeem, Anna Sandberg, Marie Orre, Anna Torrång, Nicolaas A Bakker, Paul Gerard Richardson
Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study. British journal of haematology (2021)
Isabel Cuenca, Daniel Alameda, Beatriz Sanchez-Vega, David Gomez-Sanchez, Diego Alignani, Marta Lasa, Esther Onecha, Ramon Lecumberri, Felipe Prosper, Enrique M Ocio, Maria Esther González, Alfonso García de Coca, Javier De La Rubia, Mercedes Gironella, Luis Palomera, Albert Oriol, Maria Casanova, Valentin Cabañas, Francisco Taboada, Albert Pérez-Montaña, Felipe De Arriba, Noemi Puig, Gonzalo Carreño-Tarragona, Santiago Barrio, Jose Enrique de la Puerta, Angel Ramirez-Payer, Isabel Krsnik, Juan Jose Bargay, Juan Jose Lahuerta, Maria-Victoria Mateos-Manteca, Jesus F San-Miguel, Bruno Paiva, Joaquin Martinez-Lopez
Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis. Leukemia 35 (1) (2020)
Maria-Victoria Mateos-Manteca, Leah Fink, Niranchana Koneswaran, Michele Intorcia, Christina Giannopoulou, Daniela Niepel, Michele Cavo
Bone complications in patients with multiple myeloma in five European countries: a retrospective patient chart review. BMC cancer 20 (1) (2020)
Hartmut Goldschmidt, Meletios A Dimopoulos, S Vincent Rajkumar, Katja C Weisel, Philippe Moreau, Wee-Joo Chng, Gábor Mikala, Michele Cavo, Karthik Ramasamy, Kaveri Suryanarayan, Zhaoyang Teng, Richard Labotka, Maria-Victoria Mateos-Manteca
Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma. Leukemia 34 (11) (2020)
Maria-Victoria Mateos-Manteca, Shaji K Kumar, Meletios- Athanasios Dimopoulos, Verónica González-Calle, Efstathios Kastritis, Roman Hajek, Carlos Fernández De Larrea, Gareth J Morgan, Giampaolo Merlini, Hartmut Goldschmidt, Catarina Geraldes, Alessandro Gozzetti, Charalampia Kyriakou, Laurent Garderet, Markus Hansson, Elena Zamagni, Dorotea Fantl, Xavier Leleu, Byung-Su Kim, Graça Esteves, Heinz Ludwig, Saad Z Usmani, Chang-Ki Min, Ming Qi, Jon Ukropec, Brendan M Weiss, Sundararajan Vincent Rajkumar, Brian G M Durie, Jesús San F Miguel
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM). Blood cancer journal 10 (10) (2020)
Juan-José Garcés, Gabriel Bretones, Leire Burgos, Rafael Valdes-Mas, Noemi Puig, Maria-Teresa Cedena, Diego Alignani, Idoia Rodriguez, Diana Álvarez Puente, Miguel-García Álvarez, Ibai Goicoechea, Sara Rodriguez, Maria-Jose Calasanz, Xabier Agirre, Juan A Flores-Montero, Luzalba Sanoja-Flores, Paula Rodriguez-Otero, Rafael Rios, Joaquin Martinez-Lopez, Pamela Millacoy, Luis Palomera, Rafael A Del Orbe, Albert Pérez-Montaña, Halima El Omri, Felipe Prosper, Maria-Victoria Mateos-Manteca, Laura Rosiñol, Joan Blade, Juan-Jose Lahuerta, Alberto Orfao, Carlos López-Otín, Jesus F San Miguel, Juan José Lahuerta, null null
Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma. Leukemia 34 (11) (2020)
Meletios A Dimopoulos, Ruben Niesvizky, Katja Weisel, David S Siegel, Roman Hajek, Maria-Victoria Mateos-Manteca, Michele Cavo, Mei Huang, Anita Zahlten-Kumeli, Philippe Moreau
Once- versus twice-weekly carfilzomib in relapsed and refractory multiple myeloma by select patient characteristics: phase 3 A.R.R.O.W. study subgroup analysis. Blood cancer journal 10 (3) (2020)
Luciano José Megale Costa, Benjamin A Derman, Susan Bal, Surbhi Sidana, Saurabh Chhabra, Rebecca Silbermann, Jing C Ye, Curly T C M Morris, Robert F Cornell, Sarah A Holstein, Qian Shi, James Omel, Natalie S Callander, Wee Joo Chng, Vania Hungria, Ângelo Maiolino, Edward Stadtmauer, Sergio A Giralt, Marcelo Pasquini, Andrzej J Jakubowiak, Gareth J Morgan, Amrita Krishnan, Graham H Jackson, Mohamad Mohty, Maria-Victoria Mateos-Manteca, Meletious A Dimopoulos, Thierry Facon, Andrew Spencer, Jesus San Miguel, Parameswaran Hari, Saad Z Usmani, Salomon Manier, Phillip McCarthy, Shaji K Kumar, Francesca Gay, Juan José Lahuerta
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials. Leukemia 35 (1) (2020)
Dolly A Parasrampuria, Jianming He, Liping Zhang, Bogdan Muresan, Peter Hu, Sepideh Nemat, Mahmoud Hashim, Annette Lam, Carlos Appiani, Michele Cavo, Meletios A Dimopoulos, Jesus San-Miguel, Maria-Victoria Mateos-Manteca
Comparison of efficacy from two different dosing regimens of bortezomib: an exposure-response analysis. British journal of haematology 189 (5) (2020)
Joaquin Martinez Lopez, Maria-Victoria Mateos-Manteca, Cristina Encinas, Anna Sureda, José Ángel Hernández-Rivas, Ana Lopez de la Guía, Diego Conde, Isabel Krsnik, Elena Prieto, Rosalía Riaza Grau, Mercedes Gironella, María Jesús Blanchard, Nerea Caminos, Carlos Fernández de Larrea, María Alicia Senin, Fernando Escalante, José Enrique de la Puerta, Eugenio Giménez, Pilar Martínez-Barranco, Juan José Mateos, Luis Felipe Casado, Joan Bladé, Juan-José Lahuerta, Javier de la Cruz, Jesús San F Miguel
Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality. Blood cancer journal 10 (10) (2020)
Alejandro Medina Herrera, Noemi Puig, Juan A Flores-Montero, Cristina Jimenez, María Eugenia Sarasquete, María Garcia-Alvarez, Isabel Prieto-Conde, Carmen Chillon, Miguel Alcoceba, Norma C Gutierrez, Albert Oriol, Laura Rosinol, Joan Bladè, Mercedes Gironella, Miguel T Hernandez, Veronica Gonzalez-Calle, Maria-Teresa Cedena, Juan José Lahuerta, Jesús San F Miguel, Juan-José Lahuerta, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Alberto Orfao, Marcos Gonzalez, Miriam Santero
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma. Blood cancer journal 10 (10) (2020)
Enrique María Ocio, Cristina Motlló, Paula Rodríguez-Otero, Joaquin Martinez-Lopez, Mª José Cejalvo, Jesús Martín-Sánchez, Joan Bladé, Mª Dolores García-Malo, Mª Victoria Dourdil, Aránzazu García-Mateo, Felipe de Arriba, Ramón García-Sanz, Javier de la Rubia, Albert Oriol, Juan-José Lahuerta, Jesús San F Miguel, Maria-Victoria Mateos-Manteca
Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1-acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group. British journal of haematology 192 (3) (2020)
Evangelos Terpos, Monika Engelhardt, Gordon Cook, Francesca Gay, Maria-Victoria Mateos-Manteca, Ioannis Ntanasis-Stathopoulos, Niels W C J van de Donk, Hervé Avet-Loiseau, Roman Hajek, Annette Juul Vangsted, Heinz Ludwig, Sonja Zweegman, Philippe Moreau, Hermann Einsele, Mario Boccadoro, Jesus San Miguel, Meletios A Dimopoulos, Pieter Sonneveld
Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN). Leukemia 34 (8) (2020)
Noemí Puig, Luis-Antonio Corchete, José J Pérez-Morán, Julio Dávila-Valls, Teresa Paíno, Javier de la Rubia, Albert Ortiol, Jesús Martín-Sánchez, Felipe de Arriba, Joan Bladé, María-Jesús Blanchard, Verónica González De La Calle, Miriam Santero, Bruno Paiva, Juan-José Lahuerta, Jesús F San-Miguel, Maria-Victoria Mateos-Manteca, Enrique María Ocio
Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial. Cancers 12 (12) (2020)
Sarah Goldman-Mazur, Artur Jurczyszyn, Jorge J Castillo, Anna Waszczuk-Gajda, Norbert Grząśko, Jakub Radocha, Max Bittrich, Klaus Martin Kortüm, Alessandro Gozzetti, Lidia Usnarska-Zubkiewicz, Julio D Valls, David S Jayabalan, Ruben Niesvizky, Julia Kelman, Daniel Coriu, Laura Rosinol, Łukasz Szukalski, Veronica González-Calle, Maria-Victoria Mateos-Manteca, Krzysztof Jamroziak, Iwona Hus, Irit Avivi, Yael C Cohen, Piotr K Mazur, Anna Suska, Aimee Chappell, Deepu Madduri, Saurabh Chhabra, Ariel Kleman, Parameswaran Hari, Michel Delforge, Paweł Robak, Massimo Gentile, Izabela Kozłowska, Stuart L Goldberg, Jacek Czepiel, Monika Długosz-Danecka, Rebecca Silbermann, Adam J Olszewski, Peter Barth, Gabor Mikala, Chor-Sang Chim, David H Vesole
Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients. Leukemia & lymphoma 61 (8) (2020)
Heinz Ludwig, Mario Boccadoro, Philippe Moreau, Jesus San-Miguel, Michele Cavo, Charlotte Pawlyn, Sonja Zweegman, Thierry Facon, Christoph Driessen, Roman Hájek, Melitios A Dimopoulos, Francesca Gay, Hervé Avet-Loiseau, Evangelos Terpos, Niklas Zojer, Mohamad Mohty, Maria-Victoria Mateos-Manteca, Hermann Einsele, Michel Delforge, Jo Caers, Katja Weisel, Graham Jackson, Laurent Garderet, Monika Engelhardt, Niels van de Donk, Xavier Leleu, Hartmut Goldschmidt, Meral Beksac, Inger Nijhof, Niels Abildgaard, Sara Bringhen, Pieter Sonneveld
Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network. Leukemia 35 (1) (2020)
Meletios- Athanasios Dimopoulos, Sagar Lonial, Darrell White, Philippe Moreau, Katja Weisel, Jesus San-Miguel, Ofer Shpilberg, Sebastian Grosicki, Ivan Špička, Adam Walter-Croneck, Hila Magen, Maria-Victoria Mateos-Manteca, Andrew Belch, Donna Reece, Meral Beksac, Andrew Spencer, Heather Oakervee, Robert Z Orlowski, Masafumi Taniwaki, Christoph Röllig, Hermann Einsele, Morio Matsumoto, Ka Lung Wu, Kenneth C Anderson, Ying-Ming Jou, Alex Ganetsky, Anil K Singhal, Paul G Richardson
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study. Blood cancer journal 10 (9) (2020)
Alejandro Medina Herrera, Cristina Jiménez, M Eugenia Sarasquete, Marcos González, M Carmen Chillón, Ana Balanzategui, María Isabel Prieto-Conde, María García-Álvarez, Noemí Puig, Verónica González-Calle, Miguel Alcoceba, Isabel Cuenca, Santiago Barrio, Fernando Escalante, Norma C Gutiérrez, Mercedes Gironella, Miguel T Hernández, Anna Sureda, Albert Oriol, Joan Bladé, Juan-José Lahuerta, Jesús F San Miguel, Maria-Victoria Mateos-Manteca, Joaquín Martínez-López, María-José Calasanz, Miriam Santero
Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients. Blood cancer journal 10 (2) (2020)
Katja C Weisel, Maria-Victoria Mateos-Manteca, Francesca Gay, Michel Delforge, Curly T C M Morris, Zsolt Szabo, Renaud Desgraz, Lucy DeCosta, Philippe Moreau
Efficacy and safety profile of deep responders to carfilzomib-based therapy: a subgroup analysis from ASPIRE and ENDEAVOR. Leukemia 35 (6) (2020)
Meletios- Athanasios Dimopoulos, Michele Cavo, Maria-Victoria Mateos-Manteca, Thierry Facon, Bart Heeg, Sophie van Beekhuizen, Samron B Gebregergish, Sandhya Nair, Marta Pisini, Annette Lam, Mary Slavcev
A matching-adjusted indirect treatment comparison (MAIC) of daratumumab-bortezomib-melphalan-prednisone (D-VMP) versus lenalidomide-dexamethasone continuous (Rd continuous), lenalidomide-dexamethasone 18 months (Rd 18), and melphalan-prednisone-thalidomide (MPT). Leukemia & lymphoma 61 (3) (2019)
Maria-Victoria Mateos-Manteca, Robert Z Orlowski, Enrique María Ocio, Paula Rodríguez-Otero, Donna Reece, Phillipe Moreau, Nikhil Munshi, David E Avigan, David S Siegel, Razi Ghori, Mohammed Z H Farooqui, Patricia Marinello, Jesús San F Miguel
Pembrolizumab combined with lenalidomide and low-dose dexamethasone for relapsed or refractory multiple myeloma: phase I KEYNOTE-023 study. British journal of haematology 186 (5) (2019)
Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Hartmut Goldschmidt, Pieter Sonneveld, Meletios- Athanasios Dimopoulos, Bart Heeg, Mahmoud Hashim, William Deraedt, Peter Hu, Annette Lam, Jianming He
The effects of different schedules of bortezomib, melphalan, and prednisone for patients with newly diagnosed multiple myeloma who are transplant ineligible: a matching-adjusted indirect comparison. Leukemia & lymphoma 61 (3) (2019)
Maria-Victoria Mateos-Manteca, Verónica González De La Calle
Timing of treatment of smoldering myeloma: early treatment. Blood advances 2 (21) (2019)